Main Menu

Hundreds of Years Combined Innovation Experience

Our Leaders

Our ability to launch new therapeutic solutions is supported by extensive leadership experience. Various team members have developed and/or launched successful products, including several that were first-in-class and/or reached iconic status. Our strategy leverages this relevant experience to meaningfully benefit underserved patients through the in-licensing, acquisition, development, and commercialization of innovative therapeutics.

Andrew Sklawer

Co-Founder, President & Chief Executive Officer

Andrew Sklawer
Andrew Sklawer

Andrew Sklawer

Co-Founder, President & Chief Executive Officer

Bert Marchio

Chief Financial Officer

Bert Marchio
Bert Marchio

Bert Marchio

Chief Financial Officer

David McAvoy

General Counsel & Chief Compliance Officer

David McAvoy, MSES, JD
David McAvoy, MSES, JD

David McAvoy

General Counsel & Chief Compliance Officer

Aron Aizenstat

Vice President, Corporate Development & Operations

Aron Aizenstat, MBA, PMP
Aron Aizenstat, MBA, PMP

Aron Aizenstat

Vice President, Corporate Development & Operations

Sue Fattor

Head of Human Resources

Sue Fattor
Sue Fattor

Sue Fattor

Head of Human Resources

Aaron Fox-Collis, CPA

Vice President, Finance & Chief Accounting Officer

Aaron Fox-Collis
Aaron Fox-Collis

Aaron Fox-Collis, CPA

Vice President, Finance & Chief Accounting Officer

James S. McElvain

Interim Head of CMC Development

James S. McElvain, PhD
James S. McElvain, PhD

James S. McElvain

Interim Head of CMC Development